Email Us
View Reports

Mesenchymal Stem Cells Market

Mesenchymal Stem Cells Market Analysis – By Application (Injuries, Drug Discovery, Cardiovascular Infraction, Others), By Source Type (Bone Marrow, Umbilical Cord Blood, Peripheral Blood, Lung Tissue, Synovial Tissues, Amniotic Fluids, Adipose Tissues), and By Region – Global Industry Size, Growth, Share, Trends, Demand, Strategy and Competitive Analysis Forecast Report 2025

  • ID : 86063286  |  
  • Published : Mar-2022  |  
  • Region : Global  |  
  • Pages : 110   |  
  • Publisher : Polaris Market Research

Mesenchymal Stem Cells Market Outline:

Mesenchymal stem cells are adult stem cells that help to replace or repair damaged tissue. Preclinical studies on the use of mesenchymal stem cells in the treatment of cardiovascular disease, liver disease, and cancer are expected to create new opportunities for this market. North America has dominated the global market and is expected to continue its dominion due to high R&D spending, the availability of advanced research facilities and qualified professionals, and government initiatives.

Mesenchymal Stem Cells Market Size, and Growth Rate:

According to the research report, the Mesenchymal Stem Cells Market size was valued USD 1,335.1 Million in 2017, it is projected to reach USD 2,518.5 Million by the end of 2026, with increasing at a CAGR of 7% during the forecast period 2018-2026. Stem cells mainly function for the replacement of damaged cell and tissues. The potential of this cell is to heal the damaged tissue with no pain to the individual. Scientists are majorly focusing on developing new and innovative treatment options for various chronic diseases like cancer. Additionally, the local governments have also taken various steps for promoting the use of these stem cells.

Mesenchymal Stem Cells Market Drivers, Challenges and Opportunities:

The global market for mesenchymal stem cells is expected to be fueled by the increasing clinical application of these cells for the treatment of chronic diseases, cartilage and bone diseases, and autoimmune diseases. Studies have shown that these stem cells improve angiogenesis in the myocardium and allow the reduction of the myocardial fibrotic area. Preclinical studies on the use of mesenchymal stem cells in the treatment of cardiovascular disease, liver disease, and cancer are expected to create new opportunities for this market. Mesenchymal stem cells also produce anti-inflammatory molecules that modulate humoral and cellular immune responses. With the characteristics of these stem cells, such as ease of isolation, regenerative potential, and immunoregulation, mesenchymal stem cell therapy has become a promising tool for the treatment of chronic, degenerative, inflammatory and autoimmune diseases.

However, research on these stem cells is tedious, time-consuming and complex. Conflicting results and regulatory compliance of approvals can also hinder the growth of this market. MSC will overexpress antitumor genes for use in the treatment of cancer, which represents new opportunities in the therapeutic field. In some cases, due to some adverse effects, grafted mesenchymal stem cells are rapidly removed from the body, limiting the use of stem cells in therapeutic treatments.

Mesenchymal Stem Cells Market Growth:

The global mesenchymal stem cells market growth is primarily driven by the increasing demand for these stem cells as an effective treatment alternative for knee replacement in the recent past. Furthermore, increasing elderly population across the globe and rising prevalence of various chronic diseases including cancer, autoimmune diseases, bone and cartilage diseases are factors expected to boost the market growth during the forecast period. In addition, effective government policies, and funding for research and development would positively influence the market growth over the coming years. However, some of the political point of views, and higher cost of treatment by using mesenchymal stem cells might restraint the growth during the forecast period. Increasing demand for better healthcare facilities, rising geriatric population across the globe, and continuous research and development activities in this area by the key players is expected to have a positive impact on the growth of Mesenchymal Stem Cells market.

Mesenchymal Stem Cells Market Regional Presence:

North America generated the highest revenue in 2017 and is expected to be the leading region globally during the forecast period. The Asia Pacific market is also expected to witness significant market growth in the coming years. Developing healthcare infrastructure among countries such as China, India in this region is observed to be the major factor in promoting the growth of this market during the forecast period.

Some of the promising companies leading the Mesenchymal Stem Cells Market:

  • Cell Applications, Inc.
  • Cyagen Biosciences Inc
  • Axol Bioscience Ltd.
  • Cytori Therapeutics Inc.
  • Stem cell technologies Inc.
  • Celprogen, Inc
  • BrainStorm Cell Therapeutics
  • Stemedica Cell Technologies, Inc

Detailed Classification of the Mesenchymal Stem Cells Market:

Mesenchymal Stem Cells Market – By Application:

  • Injuries
  • Drug Discovery
  • Cardiovascular Infraction
  • Others

Mesenchymal Stem Cells Market – By Source Type:

  • Bone Marrow
  • Umbilical Cord Blood
  • Peripheral Blood
  • Lung Tissue
  • Synovial Tissues
  • Amniotic Fluids
  • Adipose Tissues

Mesenchymal Stem Cells Market – By Geographical Segmentation:

  • North America                                                 

    • United States                                
    • Canada                                          

  • Europe                                                                                  

    • United Kingdom                                            
    • Germany                                       
    • France                                           
    • Italy                                
    • Spain                                             

  • Asia-Pacific                                                      

    • China                                             
    • India                                              
    • Japan                                             
    • South Korea                                  

  • Latin America                                                                              

    • Brazil                                             
    • Argentina                                      
    • Mexico                                          

  • Middle-East & Africa                                                       

    • Middle-East                                  
    • Africa       

Key Takeaways from Mesenchymal Stem Cells Market Report:

  • For different Devices types, and applications offers calculated growth rates (CAGR %), Volume (Units), and Value ($M) in each region to estimate the Mesenchymal Stem Cells Market potential.
  • Identify various driving factors, constraints and untold opportunities that can impact the Mesenchymal Stem Cells Marketplace
  • Know the position of your competitor based on the market shares, financial performance, strategical approaches, SWOT, product benchmarking and so on.
  • Increase overall revenue by understanding the geographical impact on sales and distribution channels.
  • Evaluate the increase in values at each step of the industry supply chain to improve process efficacy and optimize the value.
  • Understand the market dynamics of leading players like deals, partnerships, new products, mergers and acquisitions in the last four years.
  • Estimate the gaps in supply-demand, statics involved in import-export, and regulatory framework of the worldwide Mesenchymal Stem Cells Market in over 20 top nations.

**The report can be customized as per your requirements, please write your requirements to sales@researchcosmos.com and we will try to revert at the possible earliest.

Table of Contents

1. Overview and Scope

1.1. Research goal & scope

1.2. Research assumptions

1.3. Research Methodology

1.3.1. Primary data sources

1.3.2. Secondary data sources

1.4. Key takeaway

1.5. Stakeholders

2. Executive Summary

2.1. Market Definition

2.2. Market Segmentation

3. Mesenchymal Stem Cells Market Insights

3.1. Mesenchymal Stem Cells – Industry snapshot

3.2. Mesenchymal Stem Cells - Ecosystem analysis

3.3. Mesenchymal Stem Cells Market Dynamics

3.3.1. Mesenchymal Stem Cells – Market Forces

3.3.2. Mesenchymal Stem Cells Market Driver Analysis

3.3.3. Mesenchymal Stem Cells Market Restraint/Challenges analysis

3.3.4. Mesenchymal Stem Cells Market Opportunity Analysis

3.4. Industry analysis - Porter's five force

3.4.1. Bargaining power of supplier

3.4.2. Bargaining power of buyer

3.4.3. Threat of substitute

3.4.4. Threat of new entrant

3.4.5. Degree of competition

3.5. Mesenchymal Stem Cells Market PEST Analysis

3.6. Mesenchymal Stem Cells Market Value Chain Analysis

3.7. Mesenchymal Stem Cells Industry Trends

3.8. Competitive Ranking Analysis

4. Mesenchymal Stem Cells Market Size and Forecast by Source Type, 2018-2026

4.1. Key Findings

4.2. Bone Marrow

4.3. Umbilical Cord Blood

4.4. Peripheral Blood

4.5. Lung Tissue

4.6. Synovial Tissues

4.7. Amniotic Fluids

4.8. Adipose Tissues.

5. Mesenchymal Stem Cells Market Size and Forecast by Application Type, 2018-2026

5.1. Key Findings

5.2. Injuries

5.3. Drug Discovery

5.4. Cardiovascular Infraction

5.5. Others

6. Mesenchymal Stem Cells Market Size and Forecast by Region, 2018-2026

6.1. Key Findings

6.2. North America

6.2.1. U. S.

6.2.2. Canada

6.3. Europe

6.3.1. Germany

6.3.2. UK

6.3.3. France

6.3.4. Italy

6.3.5. Spain

6.3.6. Russia

6.3.7. Rest of Europe

6.4. Asia-Pacific

6.4.1. China

6.4.2. India

6.4.3. Japan

6.4.4. Singapore

6.4.5. Malaysia

6.4.6. Australia

6.4.7. Rest of Asia-Pacific

6.5. Latin America

6.5.1. Mexico

6.5.2. Brazil

6.5.3. Argentina

6.5.4. Rest of LATAM

6.6. Middle East & Africa

7. Company Profiles

7.1. Cell Applications, Inc.

7.1.1. Overview

7.1.2. Financials

7.1.3. Product Benchmarking

7.1.4. Recent Developments

7.2. Cyagen Biosciences Inc.

7.2.1. Overview

7.2.2. Financials

7.2.3. Product Benchmarking

7.2.4. Recent Developments

7.3. Axol Bioscience Ltd.

7.3.1. Overview

7.3.2. Financials

7.3.3. Product Benchmarking

7.3.4. Recent Developments

7.4. Cytori Therapeutics Inc.

7.4.1. Overview

7.4.2. Financials

7.4.3. Product Benchmarking

7.4.4. Recent Developments

7.5. Stem cell technologies Inc.

7.5.1. Overview

7.5.2. Financials

7.5.3. Product Benchmarking

7.5.4. Recent Developments

7.6. Celprogen, Inc.

7.6.1. Overview

7.6.2. Financials

7.6.3. Product Benchmarking

7.6.4. Recent Developments

7.7. BrainStorm Cell Therapeutics.

7.7.1. Overview

7.7.2. Financials

7.7.3. Product Benchmarking

7.7.4. Recent Developments

7.8. Stemedica Cell Technologies, Inc.

7.8.1. Overview

7.8.2. Financials

7.8.3. Product Benchmarking

7.8.4. Recent Developments

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?